CPTx
Genetic Medicine
1 open roleGenetic MedicineMunich, Germany43 employees$29M raisedEst. 2021
BlueYard Capital
SPRIND
Bayern Kapital
Marius Nacht Group
Andrej Henkler
Stefan Oschmann
About CPTx
- CPTx is a genetic medicines company pioneering the development of in vivo genetic medicines built with single-stranded DNA.
- They develop programmable DNA nanofabrication designed to neutralize viruses by putting them into molecular cages, with a current focus on infectious diseases.
CPTx is listed on Rocketlist with 1 active role. The company is categorized as Genetic Medicine in BioTech. CPTx is at Series B stage, with a B2B business model, headquartered in Munich, Germany. CPTx was founded in 2021 and has 43 employees. CPTx has raised $29M. Active roles are refreshed daily from public hiring sources.